12 results
6-K
EX-99.4
GRCL
Gracell Biotechnologies Inc
26 Dec 23
Voting and Support Agreement
8:12am
experts will be instrumental in continuing to advance the companies’ combined vision and mission. William will also be a member of the Oncology Cell
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
7 Aug 23
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
8:07am
FasTCAR GC012F candidate for hematological cancers and autoimmune diseases, and their support for our mission to develop revolutionizing cell
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
16 Nov 22
Current report (foreign)
6:03am
Gracell with a mission to develop highly efficacious and affordable breakthrough cell therapies that address vast unmet needs and we look forward
424B4
zfl981s
8 Jan 21
Prospectus supplement with pricing info
1:42pm
F-1/A
zg3dzjf2fcjx 8jy74
7 Jan 21
Registration statement (foreign) (amended)
7:03am
F-1/A
3okmo3 ct4jow3mbgb
6 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
6rhyutt2jstm 3cz6o2
4 Jan 21
Registration statement (foreign) (amended)
9:30am
F-1
srm 2f96uu
18 Dec 20
Registration statement (foreign)
4:18pm
DRS/A
iyjkjj
24 Nov 20
Draft registration statement (amended)
12:00am
DRS
9rnrqhm 3admzwz
19 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next